日本語 
Pharma
Hitachi, Ltd. has entered a licensing agreement with Shionogi & Co., Ltd. to roll out a generative AI solution that supports the creation of regulatory documents in drug development. The…
Hitachi and KSK Team Up on Pharma Delivery Digitalization
KSK Corporation and Hitachi, Ltd. have begun a collaborative creation project to…
Eisai seeks FDA approval for LEQEMBI Subcutaneous dose
Eisai Co., Ltd. and Biogen Inc. have started a rolling supplemental Biologics…
MEDIPAL and JCR Ink Global Deal for GM2 Drug JR-479
MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced that the two…
Eisai’s Tazemetostat Approved as Orphan Drug in Japan
Eisai Co., Ltd. announced that it has received orphan drug designation for…
Austria and Germany First in EU to Launch LEQEMBI
Eisai Co., Ltd. and Biogen Inc. shared that LEQEMBI (lecanemab), an anti-amyloid…
JDSC launches Smart Factory for pharma manufacturing
JDSC Co., Ltd. has launched a smart factory project to advance pharmaceutical…
Elix Provides AI Drug Discovery Platform “Elix DiscoveryTM” to KYORIN Pharmaceutical
Elix, Inc., a Japan-based AI drug discovery company, is pleased to announce…
Eisai’s Insomnia drug DAYVIGO approved for Use in China
Eisai Co., Ltd. DAYVIGO® (lemborexant) has been approved in China, where it’s…
English